Cardiogenic shock in the setting of acute myocardial infarction remains a major cause of
morbidity and mortality. In fact, acute myocardial infarction accounts for 81% of patients in …

Up to 10% of acute coronary syndromes are complicated by cardiogenic shock (CS) with
contemporary mortality rates of 40–50%. The extent of ischemic myocardium has a profound …

Cardiogenic shock (CS) remains the most common cause of death in patients with acute
myocardial infarction although mortality could be reduced from formerly∼ 80% to 40–50 …

Despite advances in percutaneous coronary interventions and their widespread use,
mortality in patients presenting with acute myocardial infarction (MI) complicated by …

Despite efforts at early revascularization in acute coronary syndrome and advancing
technologies in the field of temporary mechanical circulatory support (TMCS), the mortality …

Cardiogenic shock is a life-threatening condition that occurs in response to reduced cardiac
output in the presence of adequate intravascular volume and results in tissue hypoxia …

Cardiogenic shock is the leading cause of death among patients hospitalized with acute
myocardial infarction. It is defined as tissue hypoperfusion resulting from ventricular pump …

Cardiogenic shock is a common clinical condition with high in‐hospital mortality. Early
application of appropriate interventions for cardiogenic shock—including medical therapies …

OBJECTIVES: To review a contemporary approach to the management of patients with
cardiogenic shock (CS). DATA SOURCES: We reviewed salient medical literature regarding …

Despite the advancements in the pharmacologic treatment of acute myocardial infarction,
the mortality rate for cardiogenic shock has remained between 70% and 80%, with …